BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: BTX 1702 Rosacea Study Approval, page-21

  1. 2,759 Posts.
    lightbulb Created with Sketch. 589
    The key element is defining "success" and "failure", and IMO agents on the web, including HC, have this assigned task as part of such groups. I have, for example, delineated "the Choir" and some of its activities with respect to Botanix.

    As for the reason BOT is being given the "full treatment", I believe there are people who are not pleased with the way in which Botanix has raised capital or with the amount of cash the company has on hand. I think these people would prefer more shares at a steep discount on a depressed share price (after which the share price would "miraculously" recover).

    Yours faithfully

    A. Cynic Realist
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
38.0¢
Change
0.055(16.9%)
Mkt cap ! $687.8M
Open High Low Value Volume
33.0¢ 38.0¢ 33.0¢ $7.103M 19.63M

Buyers (Bids)

No. Vol. Price($)
5 134000 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 650314 19
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.